Insulin-Lowering Medications in Polycystic Ovary Syndrome
September 2000
in “
Obstetrics and Gynecology Clinics of North America
”
insulin-lowering medications Polycystic Ovary Syndrome PCOS menstrual dysfunction hyperandrogenism metformin androgen levels ovulation thiazolidinediones insulin levels testosterone levels troglitazone rosiglitazone pioglitazone d-chiro-inositol PCOS insulin-lowering drugs menstrual issues high androgen levels metformin ovulation improvement thiazolidinediones insulin reduction testosterone reduction troglitazone rosiglitazone pioglitazone d-chiro-inositol
Studysummary This article reviews evidence on hyperinsulinemia and insulin resistance in women with polycystic ovary syndrome and evaluates therapeutic responses to insulin-lowering agents, reporting no new clinical findings.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doi.org →